← Leaderboards
John Linforth Daiss
First Wave Technologies, Inc.
$3,148,392
Attributed
$3,148,392
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $607.9K · FY2008–21$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,148,392 · 6
By mechanism
P50$1,441,469 · 1
R43$1,098,445 · 3
R21$422,489 · 1
R41$185,989 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Diagnostic”
- Bambra Strokes · Ppd Development Lp$526,656,217
- David R. Weir · University Of Michigan At Ann Arbor$380,905,171
- Leonard Freedman · Leidos Biomedical Research, Inc.$293,634,608
- David Heimbrook · Leidos Biomedical Research, Inc.$223,969,650
- Ralph Parchment · Leidos Biomedical Research, Inc.$159,723,588
- Barbara Driver · Westat, Inc.$149,946,903
Research focus
DiagnosticAntibodiesInfectionIn VitroSamplingBiological MarkersAntigensBloodWhole BloodImmunoglobulin-Secreting CellsCellsStaphylococcus AureusProteinsResearch PersonnelBaseMicrobial BiofilmsCustomBoneAntibioticsIn VivoCommunicable DiseasesAnimalsNovel StrategiesOsteomyelitis
Grant awards (12)
Core 1: Osteoimmunology Core$278,924
P50 · FY2021 · AR · contact PI
Core 1: Osteoimmunology Core$300,546
P50 · FY2020 · AR · contact PI
Novel Diagnostics for Early Lyme Disease$298,875
R43 · FY2019 · AI · contact PI
Core 1: Osteoimmunology Core$252,995
P50 · FY2019 · AR · contact PI
Core 1: Osteoimmunology Core$310,306
P50 · FY2018 · AR · contact PI
Novel Diagnostics for Early Lyme Disease$297,553
R43 · FY2018 · AI · contact PI
Core 1: Osteoimmunology Core$298,698
P50 · FY2017 · AR · contact PI
Diagnosis of early Staphylococcus aureus infections using circulating plasmablasts$192,239
R21 · FY2017 · AI · contact PI
Diagnosis of early Staphylococcus aureus infections using circulating plasmablasts$230,250
R21 · FY2016 · AI · contact PI
Anti-Autolysin Passive Immunity for MRSA Osteomyelitis$326,193
R43 · FY2010 · AI · contact PI
Coupled Gene Delivery and Protein Transduction for the Reduction of Atheroscleros$175,824
R43 · FY2009 · HL · contact PI
Use of GtfB as a Diagnostic for Caries Activity$185,989
R41 · FY2008 · DE · contact PI